Silo Pharma, Inc.
677 N. Washington Blvd.
Sarasota, Florida 34236
January 26, 2024
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Bradley Ecker
| Re: | Silo Pharma, Inc. | |
| Registration Statement on Form S-3 | ||
| File No. 333- 276658 | ||
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Silo Pharma, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Tuesday January 30, 2024, or as soon thereafter as possible.
Please notify Greg Carney of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (213) 617-4209 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
| SILO PHARMA, INC. | ||
| By: | /s/ Eric Weisblum | |
| Name: | Eric Weisblum | |
| Title: | Chief Executive Officer | |
